Australia, June 27 -- AbbVie Inc., owns the trademark (2604556) for 'LYRZO' till Nov. 18, 2035.
Status: registered:
Registered/protected
Class: 5 [Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions]
Type of Mark: Word
Date of Acceptance: Dec. 17, 2025
Registration Advertised: June 26
For further details contact Ashurst Australia.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2604556.
Disclaimer: Curated by HT Syndication.
